Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province

Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province

ObjectiveThere is a lack of studies investigating the safety of combination regimens specifically for cardiovascular and cerebrovascular diseases. This study aimed to evaluate the safety of combination drugs for cardiovascular and cerebrovascular diseases using real-world data.MethodsWe analyzed adv...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jia Wang, Yuhang Zhao, Zherui Chen, Rui Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	cardiovascular diseases cerebrovascular diseases adverse drug reaction association rule Ω shrinkage measurement
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1451713/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of ioversol and iodixanol related adverse drug reactions in cerebrovascular interventional procedures
by: Ai-bin. Guo, et al.
Published: (2025-07-01)

Review on application and development of pharmacogenomics of adverse drug reactions
by: Hongyu Bi, et al.
Published: (2025-03-01)

GENDER CHARACTERISTICS OF ADVERSE DRUG REACTIONS DEVELOPMENT: EXPERIENCE OF REGIONAL DATABASE ANALYSIS
by: A. V. Matveev, et al.
Published: (2022-05-01)

Comparative Analysis of International Databases of Adverse Drug Reactions
by: A. S. Kazakov, et al.
Published: (2020-09-01)

Risk Assessment of Linezolid-Associated Neurological Adverse Drug Reactions Based on the Food and Drug Administration Adverse Event Reporting System Database
by: Yin J, et al.
Published: (2025-05-01)

Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries
by: Mohammed Gebre Dedefo, et al.
Published: (2025-08-01)

Spontaneous Adverse Drug Reaction Reporting of Congenital Malformations: A Danish National Register Study
by: Ulrik Lausten-Thomsen, et al.
Published: (2025-06-01)

COMPARATIVE REVIEW OF METHODOLOGIES FOR ESTIMATING THE COST OF ADVERSE DRUG REACTIONS IN THE RUSSIAN FEDERATION AND BRAZIL
by: G. I. Syraeva, et al.
Published: (2021-03-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
by: S. K. Zyryanov, et al.
Published: (2020-05-01)

Adverse drug reaction to tremelimumab and durvalumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database
by: Wei Fan Sui, et al.
Published: (2025-08-01)

Rational Organisation of Adverse Drug Reaction Monitoring
by: L. V. Shukil, et al.
Published: (2022-10-01)

Evaluation and study of adverse reactions to imiglucerase based on the FAERS database
by: Pan Hong, et al.
Published: (2025-08-01)

STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTS
by: Rinto Susilo, et al.
Published: (2025-06-01)

REPORTING OF ADVERSE DRUG REACTIONS BY PATIENTS IN BULGARIA
by: Hristo Zaykov, et al.
Published: (2025-04-01)

Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them
by: N. V. Pyrikova, et al.
Published: (2019-11-01)

Common adverse cutaneous drug reaction patterns and the causative drugs in Malaysia
by: N. H. Talib, et al.
Published: (2015-07-01)

Evaluation of Surveillance System for Adverse Drug Reaction Due to Antiretroviral Drugs, Mazowe District, Zimbabwe, 2021
by: Godwin Choga, et al.
Published: (2025-01-01)

Potential inappropriate medications and drug–drug interactions in adverse drug reactions in the elderly: a retrospective study in a pharmacovigilance database
by: Huaqiao Jiang, et al.
Published: (2025-04-01)

Genetic Risk Factors for Adverse Drug Reactions
by: D. A. Sychev, et al.
Published: (2022-04-01)

Pattern of adverse drug reactions to anticancer drugs: A quantitative and qualitative analysis
by: Shruti Singh, et al.
Published: (2017-01-01)

Cutaneous adverse drug reactions and their impact on the quality of life of patients: a study at a tertiary care centre
by: Shivani, et al.
Published: (2025-07-01)

Establishment and validation of a risk prediction model for adverse drug reactions in patients with coronary heart disease after taking statins: a retrospective study
by: Lixiang Zhang, et al.
Published: (2025-07-01)

Evaluation of Social and Clinical Factors Associated with Adverse Drug Reactions Among Children with Drug-Resistant Tuberculosis in Pakistan
by: Muhammad Soaib Said, et al.
Published: (2025-06-01)

Knowledge and Practice about Adverse Drug Reactions among Pharmacists in Nadiad City
by: Anand Bharatkumar Pithadia, et al.
Published: (2018-07-01)

The characteristics of adverse reactions of three anti-prostate cancer drugs based on Vigiaccess database and bibliometric analysis
by: Jianqing Wang, et al.
Published: (2025-03-01)

Risk factors for severe adverse drug reactions in hospitalized patients
by: Petrović Nemanja Z., et al.
Published: (2025-01-01)

Self-reporting of adverse drug reactions of nonsteroidal anti-inflammatory drugs in community pharmacies
by: Phayom Sookaneknun Olson, et al.
Published: (2025-12-01)

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
by: Xi-Feng Wang, et al.
Published: (2025-01-01)

Effectiveness of mobile applications in enhancing adverse drug reaction reporting: a systematic review
by: Liyanage PH, et al.
Published: (2025-05-01)

Descriptive analysis of the national drug adverse events (AEs) database in Lebanon
by: Rita Karam, et al.
Published: (2025-12-01)

Case report: Eczematous adverse drug reaction after selpercatinib treatment
by: Bingrun Li, et al.
Published: (2024-12-01)

Adverse drug reactions related to methotrexate: a real-world pharmacovigilance study using the FAERS database from 2004 to 2024
by: Siyu Liu, et al.
Published: (2025-06-01)

Cerebrovascular disease in pediatric patients
by: Rotta Newra Tellechea, et al.
Published: (2002-01-01)

Dealing with adverse drug reactions in the context of polypharmacy using regression models
by: Jakob Sommer, et al.
Published: (2024-11-01)

Corrigendum: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
by: Xi-Feng Wang, et al.
Published: (2025-02-01)

Effect of chronic kidney disease on adverse drug reactions to anti-tubercular treatment: a retrospective cohort study
by: Divya Datta, et al.
Published: (2024-12-01)

Doença cerebrovascular: aquisição de linguagem em pré-escolares Cerebrovascular disease: language acquisition in preschool children
by: Karina Tamarozzi de Oliveira, et al.
Published: (2005-09-01)

Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program
by: Tinashe Mudzviti, et al.
Published: (2012-11-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

Prediction of adverse drug reactions based on pharmacogenomics combination features: a preliminary study
by: Mingxiu He, et al.
Published: (2025-03-01)